Companies / Candel Therapeutics, Inc. / Activity

Activity — Candel Therapeutics, Inc.

1 move.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 23, 2026Paul B Manning
Director
BuyCommon Stock$3.00M+550K
+24.87%
2,763,527
3.61% of shares
high
← PrevPage 1 of 1Next →